GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Omnia Wellness OMWS · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2023

Revenue

$290,715

FY2016FY2023

Net income

−$5.5m

FY2016FY2023

Free cash flow

−$2.4m

FY2016FY2023

Shareholders' equity

−$5.2m

FY2016FY2023

Income statement

Fiscal years

FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$290,715$290,715$218,874$223$11,820—$13,000—
Research and development$1.0m$1.0m————$4,000—
Operating income−$3.4m−$3.4m−$1.6m−$33,671−$1,917−$26,827−$1,400−$1,000
Net income−$5.5m−$5.5m−$2.2m−$33,680−$13,899−$27,584−$1,684−$1,000
Diluted earnings per share-0.02-0.02-0.01-0.00-0.00-0.00-0.00-0.00

Balance sheet

At each fiscal year end

FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$2.4m$2.4m$2.2m$2,361$1,268$3,676$4,625$5,085
Cash and short-term investments$1,894—$28,761$10$1,053$3,191$3,869$2,999
Total liabilities$7.6m$7.6m$5.6m$33,013$15,300$3,809$4,309$3,085
Debt$6.1m$1.8m$5.0m$18,546$11,509$3,809$4,309$999
Shareholders' equity−$5.2m−$5.2m−$3.4m−$33,013−$14,032−$133$316$2,000
Shares outstanding232m232m227m822m826m796m826m826m

Cash flow

Fiscal years

FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−$2.2m−$2.2m−$1.6m−$22,789−$9,838−$27,313−$3,440$1,090
Capital spending−$269,251−$269,251−$2.2m−$60−$60,266——−$2,090
Free cash flow−$2.4m−$2.4m−$3.8m−$22,849−$70,104−$27,313−$3,440−$1,000

Latest quarters

By quarter end

Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020
Revenue$28,446$133,646$138,951$56,833$57,809$218,874$218,874$102,261
Operating income−$451,976−$346,001−$1.4m−$687,288−$774,438−$1.6m−$1.6m−$9,383
Net income−$634,617−$579,525−$2.8m−$771,268−$1.5m−$2.2m−$2.2m−$9,383
Diluted earnings per share-0.00-0.00-0.01-0.00-0.01-0.01-0.01-0.00
Cash from operations———−$1.0m—−$1.0m−$1.0m—
Capital spending—————−$2.0m——
Free cash flow—————−$3.0m——
Total assets$2.1m$2.3m$2.4m$2.3m$2.3m$2.2m$2.2m$1.9m
Cash and short-term investments−$1,108——$28,697$67,326$28,761—$613
Debt$6.2m$401,838$1.8m$5.6m$5.9m$4.0m$1.3m$28,061
Shareholders' equity−$6.3m−$5.7m−$5.2m−$4.2m−$4.2m−$3.4m−$3.4m−$81,354

Growth per year

Compound annual rate

3 years5 years10 years
Revenue991.8%——
Operating income365.5%163.3%—
Net income447.3%188.6%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-1168.0%-1055.3%——
Net margin-1899.7%-1663.1%——

Valuation history

At each fiscal year end

FY2023FY2022FY2021FY2020FY2019
Price to earnings—-0.0—-0.3-0.1
Price to sales0.00.50.048.00.1

Share price return

Finished calendar years

2025202420232022202120202019
Return0%0%-81%760%141%1176%320%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 15-for-1 split · 9 Apr 2021
  • 12.6374-for-1 split · 19 Mar 2020

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.